Phase 1/2 Dose Finding, Safety and Efficacy Study of Ibrutinib inPediatric Subjects with Chronic Graft Versus Host Disease(cGVHD)

Project: Research project

Project Details

Description

Phase 1/2 Dose Finding, Safety and Efficacy Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)
StatusActive
Effective start/end date8/1/188/1/22

Funding

  • PHARMACYCLICS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.